Quality lung cancer screening protects quality of life: No harm, no foul


  • Jamie S. Ostroff PhD

    Corresponding author
    1. Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York
    • Corresponding author: Jamie S. Ostroff, PhD, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave, 7th Floor, New York, NY 10022; Fax: (212) 888-2584; ostroffj@mskcc.org

    Search for more papers by this author

  • See referenced original article on pages 3401–9, this issue.


This ancillary paper from the National Lung Screening Trial (NLST) dataset examines the impact of undergoing low-dose spiral computed tomography (LDCT) for early detection of lung cancer on health related quality of life and state anxiety assessed at 1 and 6 months following lung screening. Outcomes are compared by screening results. Overall, the findings provide reassurance that undergoing lung cancer screening in the context of a well-designed screening and follow-up protocol poses little or no psychological harm or quality of life impairment to screening participants.